Cargando…
Increased Interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease
BACKGROUND: Interleukin-35 (IL-35) is a newly identified IL-12 cytokine family member, which regulates the activity of immune cells in infectious diseases and autoimmune disorders. However, the regulatory function of IL-35 in Kawasaki disease is not well elucidated. METHODS: Thirty-three patients wi...
Autores principales: | Xing, Haijian, Tian, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149926/ https://www.ncbi.nlm.nih.gov/pubmed/32276581 http://dx.doi.org/10.1186/s12865-020-00348-x |
Ejemplares similares
-
The “Intermediate” CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans
por: Wildgruber, Moritz, et al.
Publicado: (2016) -
The “Intermediate” CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease
por: Kim, Yi Seul, et al.
Publicado: (2021) -
Activin a suppresses peripheral CD8(+) T lymphocyte activity in acute-phase Kawasaki disease
por: Wu, Qian, et al.
Publicado: (2021) -
Increase expression of CD177 in Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2019) -
CD14(high)CD16(+) monocytes are the main producers of Interleukin-10 following clinical heart transplantation
por: Ludwig, Kristina, et al.
Publicado: (2023)